The Six Pillars of Lifestyle Medicine in Managing Noncommunicable Diseases – The Gaps in Current Guidelines

Abstract

Background:  Noncommunicable diseases (NCDs), also known as chronic diseases that are long-lasting, are considered the major cause of death and disability worldwide, and the six pillars of lifestyle medicine (nutrition, exercise, toxic control, stress management, restorative sleep, and social connection) play an important role in a holistic management of their prevention and treatment. In addition, medical guidelines are the most accepted documents with recommendations to manage NCDs.

Objective:  The present study aims to analyze the lack of lifestyle pillars concerning the major Brazilian medical guidelines for NCDs and identify evidence in the literature that could justify their inclusion in the documents.

Method:  Brazilian guidelines were selected according to the most relevant causes of death in Brazil, given by the Mortality Information System, published by the Brazilian Ministry of Health in 2019. Journals were screened in the PUBMED library according to the disease and non-mentioned pillars of lifestyle.

Results:  Relevant causes of deaths in Brazil are acute myocardial infarction (AMI), diabetes mellitus (DM), and chronic obstructive pulmonary diseases (COPD). Six guidelines related to these NCDs were identified, and all address aspects of lifestyle, but only one, regarding cardiovascular prevention, highlights all six pillars. Despite this, a literature search involving over 50 articles showed that there is evidence that all the pillars can help control each of these NCDs.

Conclusion:  Rarely are the six pillars of lifestyle contemplated in Brazilian guidelines for AMI, DM, and COPD. The literature review identified evidence of all lifestyle pillars to offer a holistic approach for the management and prevention of NCDs.

Keywords: Noncommunicable Diseases; Life Style; Practice Guideline; Holistic Health

Resumo

Fundamento:  As doenças crônicas não transmissíveis (DCNT), também conhecidas como doenças crônicas de longa duração, são consideradas a principal causa de morte e incapacidade em todo o mundo, e os seis pilares da medicina do estilo de vida (nutrição, exercício, controle de tóxicos, manejo do estresse, saúde do sono e conexão social) desempenham um papel importante na gestão holística da sua prevenção e tratamento. Além disso, as diretrizes médicas são os documentos mais aceitos com recomendações para o manejo das DCNT.

Objetivo:  O presente estudo tem como objetivo analisar a ausência de pilares de estilo de vida nas principais diretrizes médicas brasileiras sobre as DCNT e identificar evidências na literatura que possam justificar sua inclusão nos documentos.

Método:  As diretrizes brasileiras foram selecionadas de acordo com as causas de morte mais relevantes no Brasil, informadas pelo Sistema de Informações sobre Mortalidade publicado pelo Ministério da Saúde em 2019. Os periódicos foram selecionados na biblioteca PUBMED de acordo com a doença e os pilares do estilo de vida não mencionados.

Resultados:  Causas relevantes de mortes no Brasil são o infarto agudo do miocárdio (IAM), o diabetes mellitus (DM) e as doenças pulmonares obstrutivas crônicas (DPOC). Foram identificadas seis diretrizes relacionadas a essas DCNT e todas abordam aspectos do estilo de vida, mas apenas uma, referente à prevenção cardiovascular, destaca todos os seis pilares. Apesar disso, uma pesquisa bibliográfica envolvendo mais de 50 artigos mostrou que há evidências de que todos os pilares podem ajudar no controle de cada uma dessas DCNT.

Conclusão:  Raramente os seis pilares do estilo de vida são contemplados nas diretrizes brasileiras para IAM, DM e DPOC. A revisão da literatura identificou evidências de todos os pilares do estilo de vida para oferecer uma abordagem holística para a gestão e prevenção das DCNT.

Palavras-chave: Doenças crônicas não transmissíveis; Estilo de vida; Diretrizes Clínicas; Saúde Holística

Introduction

Noncommunicable diseases (NCDs) are defined as chronic conditions that do not result from an (acute) infectious process, and thus are “not communicable”, with persistent effects that can impact daily activities and require ongoing medical attention.¹,²

According to the World Health Organization (WHO), NCDs are considered the major cause of death and disability worldwide, responsible for 71% of all of deaths.² In Brazil, it corresponds to 72% of all causes of death.³

NCDs have consequences not only for the patients, but also or the community in which they are inserted.⁴,⁵ Hence, the strategy to face the NCDs must include a holistic approach.⁶

Meanwhile, the American College of Lifestyle Medicine defines “lifestyle medicine” as “the use of evidence-based lifestyle therapeutic intervention as a primary modality, to prevent, treat and often reverse chronic disease”.⁷

The basis of lifestyle medicine practice involves six pillars: healthy eating, regular physical activity, cessation of tobacco use and toxic control, strategies to manage stress, sleep improvement, and social connections.⁸

Lifestyle, in addition to being non-invasive and having a relatively low cost, positively impacts physiological, metabolic, psychological, and social aspects. Changes in lifestyle could benefit pulmonary compliance, cardiac resistance, brain oxygenation, disposition and performance, immunity, learning process, among other aspects that contribute to reducing the incidence of NCDs.⁵,⁹-¹⁵ Therefore, lifestyle approaches play an important role in a holistic management of NCDs prevention and treatment.

By contrast, medical guidelines are the most accepted documents with recommendations to manage NCDs. The guidelines are well-known for containing the best scientific evidence available on the issue and may also consider the cost-effectiveness analysis for a clinical conduct.¹⁶,¹⁷

Therefore, the present study aims to analyze the lack of lifestyle pillars in the major Brazilian medical guidelines for NCDs and identify evidence in the literature that could justify their inclusion in the documents.

Methods

This is a review of NCD Brazilian guidelines, aiming to verify which of the six pillars of lifestyle are not addressed in the document and find evidence in the literature that could justify the inclusion of new recommendations of lifestyle changes to better manage these diseases.

The selection of the Brazilian medical guidelines was done according to relevant causes of death in Brazil, established by the Mortality Information System (SIM, in Portuguese) published by the Ministry of Health, which informs the mortality rate by International Classification of Diseases 10 (ICD 10) category.¹⁸

Journals were screened in the PUBMED library by title and abstract according to the disease and the non-mentioned pillars of lifestyle, enrolling the mechanisms of actions and benefits to manage the NCDs (^{Supplementary Material}).

Results

The SIM from 2022 reports data from 2019. Relevant causes of death in Brazil are listed in Table 1.¹⁸ As pneumonia caused by a microorganism is not considered a chronic disease, the NCDs considered for analysis were acute myocardial infarction (AMI), diabetes mellitus (DM), and chronic obstructive pulmonary diseases (COPD). The AMI is an acute event, mostly caused by a chronic condition, known as coronary heart disease, which causes blockage of blood flow; thus, AMI was included in the study.

Table 1
International Classification of Diseases 10 (ICD 10) categories and number of deaths in Brazil, in 2019

ICD-10	ICD-10 Category	Number of Deaths
I21	Acute myocardial infarction	95,557
J18	Pneumonia by microorganism not specified	64,651
E14	Diabetes mellitus not specified	50,238
J44	Other chronic obstructive pulmonary disease	41,922
X95	Assault by firing another firearm or unspecified weapon	27,916
I64	Stroke, not specified as hemorrhagic or ischemic	33,895
C34	Malignant neoplasm of bronchi and lungs	29,254
I50	Cardiac insufficiency (or heart failure)	27,080
I10	Essential hypertension	26,560
I11	Hypertensive heart disease	19,879

¹⁸
• ICD: International Classification of Diseases.

Six guidelines were identified addressing the three NCDs with the highest mortality rate in Brazil considering the ICD-10 category, including a generic category on the prevention of cardiovascular diseases and one related to coronary chronic disease, a cause of AMI.

1. Guidelines of the Brazilian Society of Cardiology on Stable Coronary Disease from 2014¹⁹

2. Fifth Guideline of the Brazilian Cardiology Society about the treatment of Acute Myocardial Infarction with elevated ST Segment from 2015²⁰

3. Guidelines of the Brazilian Society of Cardiology on Cardiovascular Prevention from 2019²¹

4. Guidelines of the Brazilian Society of Cardiology on Unstable Angina and Acute Myocardial Infarction without ST-segment Elevation from 2021²²

5. Clinical Protocol and Therapeutic Guidelines of Chronic Obstructive Pulmonary Disease, by the Ministry of Health, from 2021²³

6. Official Guideline of the Brazilian Society of Diabetes from 2022²⁴

Table 2 summarizes which lifestyle pillars were found in each of the selected guidelines.

Table 2
Lifestyle pillars presented in the medical guidelines studied

Guideline Disease	Guideline Year	Physical Activity	Diet	Toxic Control	Mental Health	Sleep Quality	Social Connections
SCAD19	2014	Yes	Yes	No	No	No	No
AMI20	2015	Yes	Yes	Yes	No	No	No
CVD21	2019	Yes	Yes	Yes	Yes	Yes	Yes
AMI22	2021	Yes	Yes	Yes	No	No	No
COPD23	2021	No	No	Yes	No	No	No
DM24	2022	Yes	Yes	No	Yes	No	Yes

Source: drafted by the authors.
• SCAD: stable coronary artery disease; AMI: acute myocardial infarction; CVD: cardiovascular disease; COPD: chronic obstructive pulmonary disease; DM: diabetes mellitus.

Acute myocardial infarction

What are the gaps?

The AMI guidelines do not mention sleep quality, mental health, and social connections. When it comes to toxic control, only the cessation of tobacco use was included in the AMI guidelines, but not in the Stable Coronary Guideline. A reduction in alcohol consumption was not mentioned in any of them.

Regarding the restorative sleep pillar, according to the descriptive study by Andrechuck and Ceolim (2015), three alterations prevail and affect the recovery process of patients with AMI: poor sleep quality, excessive daytime sleep, and high risk for obstructive sleep apnea syndrome.²⁵ Several epidemiological studies involving mixed genres, different numbers of patients, and follow-up periods were carried out to demonstrate the relation mentioned above.²⁶-³²

Lao et al.³³ (2018), in a prospective cohort study with 60,586 adults lasting 18 years, demonstrated that poor sleep quality as well as inadequate sleep duration are associated with a higher risk of cardiovascular diseases (CVDs). Ayas et al.²⁹ (2003), following up on 71,617 female adults during a 10-year study showed that short (<=5 hours) and long (>=9 hours) sleep are related to an increased risk of coronary heart disease.

Moreover, the combination of the four pillars – regular physical activity, balanced diet, toxic control, and sleep quality – has proven to reduce the risk of fatal and nonfatal CVDs, including myocardial infarction. This was tested by means of a prospective cohort study, known as MORGEN, following 8,128 men and 9,759 women for 10 to 14 years. In a single analysis of the pillars, adjusted for age, sex, and educational level, sufficient sleep duration (>=6 hours) presented a protective hazard ratio of 0.76 (95% Confidence Interval - CI 0.63 – 0.91) for composite CVD and 0.55 (95% CI 0.38 – 0.80) for fatal CVD.³⁴

Mental health disorders are associated with a higher risk of CVDs and with increased cardiovascular mortality. A cohort study with 880 patients demonstrated that mental health disorders can be considered as one of the causes of the development of the disease, as well as an aggravating factor for it, especially when it comes to AMI.³⁵ Moreover, in the INTERHEART study, conducted with almost 30,000 participants from 52 countries, psychosocial factors were considered one of the three most important risk factors associated with myocardial infarction.³⁶ Therefore, interventions focused on this pillar are essential to reducing CVD prevalence.³⁷

A social relation is the other pillar that can influence both before and after acquiring a CVD. In a systematic review and meta-analysis of longitudinal observational studies, loneliness and social isolation were associated with a higher risk for coronary heart disease and stroke.³⁸,³⁹ In addition, increased risk of morbidity and mortality after acquiring AMI are linked to social support, demonstrating how this pillar impacts the clinical outcomes of CVDs.⁴⁰

Regarding alcohol intake, Biddinger et al.⁴¹ (2022), using data from the United Kingdom's Biobank, including 371,463 unrelated individuals of European genetic descent, concluded that the well-known cardiovascular protective effects of light to moderate alcohol intake are related to a better self-reported health, involving lower smoking rates and body mass index, and higher physical activity and vegetable intake. In contrast, heavy alcohol consumption was associated with a higher increase in CVD risks.

As a complement to this study, a systematic review with 23 observational studies, including 29,457 participants, also showed that heavy alcohol consumption could provoke an immediate and continued cardiovascular risk, after the first 24 hours of intake. On the other hand, moderate consumption was associated with higher cardiovascular risk immediately after drinking, and prior to 24 hours after the intake.⁴²

Diabetes Mellitus

What are the gaps?

The shortcomings observed in the DM guideline are sleep quality and toxic control, such as the cessation of tobacco use.

Sleep disorders are considered both a risk factor and an aggravator of the disease. A systematic review and meta-analysis with no randomized prospective studies involving 22 studies with 69,329 participants showed that poor sleep quality and short sleep duration are independent risks for poorer glycemic control.⁴³ Two self-reported cross-sectional studies with 16,893 Chinese⁴⁴ and 300 patients⁴⁵ showed that DM II is associated with poor sleep quality and short sleep duration.

Moreover, laboratory evidence shows that chronic sleep loss appears to be associated with neuroendocrine and metabolic alterations, which increase the risk for DM II. In a review study, Van Cauter et al.⁴⁶ (2007) observed that these alterations affect the appetite, with lower leptin and higher ghrelin levels, and cause glucose disturbances, with lower cell responsiveness and insulin sensitivity. The hypersecretion of leptin, a hormone that increases food intake, can lead to obesity, a condition predisposed to DM II.⁴⁷

Nilsson et al.⁴⁸ (2004), studying a cohort of 6,599 Swedish middle-aged non-diabetic men, observed, in a mean follow-up of 14.8 years, that sleep deprivation increases the risk of DM type II by 52% (odds ratio 1.52 [95% CI 1.05–2.20]).

Regarding toxic controls, according to the Centers for Disease Control and Prevention (CDC),⁴⁹ the risk of smokers developing DM II is 30 to 40 percent higher than nonsmokers. This happens due to alterations in the body's functionality and cell damage caused by the chemicals, leading to oxidative stress and inflammation, and decreasing insulin effectiveness.⁴⁹-⁵²

When it comes to alcohol consumption, despite being a controversial subject, one systematic review and meta-analysis, including 20 cohort studies, confirmed the U-shaped relationship with DM II risk, in which moderate drinking presents a protective factor.⁵³ Moreover, a prospective study with 5,521 men, aged 40-59 years, showed that heavy alcohol consumption, mediated by body weight, is associated with an incidence of DM II.⁵⁴

Chronic obstructive pulmonary diseases

What are the gaps?

The COPD guideline did not address physical activity, diet, mental health, sleep quality, and social connections.

Mental health has a direct impact on COPD and can either be a cause or a consequence of the disease. A systematic review and meta-analysis were carried out using 16 studies on depression or anxiety as predictors of COPD risk or mortality, involving 28,759 individuals, and 6 studies on COPD-related conditions as a predictor of depression, involving 7,439,159 individuals. This study pointed out that anxiety and depression can negatively affect the COPD prognosis and may increase the risk of hospitalizations and exacerbations.⁵⁵

Montserrat-Capdevila et al.⁵⁶ (2018), in a prospective cohort study conducted with 512 patients with COPD, originating from a rural area in Spain, followed up between 2012 and 2014, showed that the diagnosis of anxiety and depression almost doubled the risk of hospitalization due to severe exacerbation of COPD.

Gudmundsson et al.⁵⁷ (2005), in a multicenter prospective study, involving 416 patients, in the Nordic countries, showed a higher prevalence of anxiety and depression in patients discharged after hospitalization due to an acute exacerbation of COPD.

When it comes to nutrition, there are some dietary options to be followed to improve respiratory health, specifically in preventing COPD, all derived from clinical and observational studies, such as the Mediterranean diet.⁵⁸

A cross-sectional study, conducted with 207 smokers, showed the association between the adverse effects of alcohol consumption and the Western diet, which is rich in refined food, saturated fat, meat, and sugar, with impaired lung function. In opposition, the Mediterranean diet, replete with plant-based foods and a healthy fat, seems to preserve the lung function and prevent COPD or its progression.⁵⁸

Epidemiological evidence gathered from 25 articles suggests a positive effect of fruit, fish, and vegetable intake, including benefits for the lung function and an inverse relationship to COPD mortality and respiratory symptoms. The opposite is seen for high levels of meat consumption.⁵⁹ In addition, a case-control study with 183 elderly people, including 21 individuals with COPD, showed that patients with COPD had a diet of poorer antioxidant quality.⁶⁰ The antioxidant diet was previously associated with lung health benefits in a cross-sectional study of 14,120 adults.⁶¹

Studies associating physical activity and COPD are related to the outcomes that exercises can bring for those who already have the disease. It is an important factor for pulmonary rehabilitation, requiring one to consider the duration, intensity, and modes of activity.

Worldwide, clinical practice guidelines to manage COPD were reviewed by Lewthwaite et al.⁶² (2017) from 2005 to 2017. These authors found twenty-one documents recommending physical activity to improve the COPD patients’ health outcomes.

Donaire-Gonzalez et al.⁶³ (2015) in a prospective study involving 177 patients with a 2-year follow-up, showed that a greater quantity of low-intensity physical exercise reduces the risk of COPD hospitalizations. Garcia-Aymerich et al.⁶⁴ (2006), in a prospective cohort study, conducted with 28,747 people throughout 12 years of follow-up, adds that low, moderate, and high physical activity provides a lower risk for hospitalization due to COPD.

According to Watz et al.⁶⁵ (2008) and Waschki et al.⁶⁶ (2011), in a prospective study with 170 stable COPD patients, physical inactivity or sedentarism can lead to decreased lung and heart function, systemic inflammation, and muscle weakness, which affect clinical outcomes, in addition to increasing the risk of mortality. Dogra et al.⁶⁷ (2018), in a longitudinal study with 877 Canadians with COPD, showed the negative effects of sedentary time on perceived health, mental health, and aging.

Regarding the social support pillar in COPD patients, most of the studies associated the relationship of social support with mental health aspects. DiNicola et al.⁶⁸ (2013) and Marino et al.⁶⁹ (2008), in cross-sectional studies conducted with 452 and 156 people, respectively, assessed the importance of perceived social support for COPD patients, when they have anxiety and depression as comorbidities. DiNicola et al.⁶⁸ (2013) stated that positive and negative social support were significant predictors of anxiety in COPD patients. Marino et al.⁶⁹ (2008) demonstrated that social support and self-efficacy were related to overall social functioning.

In a scoping review including 31 studies, Barton et al.⁷⁰ (2015) described that adequate social support was beneficial for self-care and adherence to treatment in COPD patients, and led to a positive outcome regarding mental health.

One review study and another carried out with 24 COPD patients associating sleep quality with COPD demonstrates the impact of the disease on one's sleep routine and how it can exacerbate the effects of the disease. Sleep disorders like insomnia are common in patients with COPD. Nocturnal oxygen desaturation occurs even in mild COPD and can reflect sleep-disordered breathing or rapid eye movement sleep-related hypoventilation.⁷¹,⁷²

Vukoja et al.⁷³ (2018) in a cross-sectional study, conducted with 100 COPD patients and 104 healthy individuals, demonstrated that those with the disease had poor sleep quality, being significantly higher when compared to the control group. Serin et al.⁷⁴ (2020) in a study with 110 COPD patients, concluded that these individuals had moderate or poor sleep quality and dyspnea.

Omachi et al.⁷⁵ (2012), in a study involving 98 adults, showed that, in a cross-sectional investigation, disturbed sleep was associated with a worsening of COPD and, in a longitudinal analysis, was associated with exacerbations, emergency healthcare use, and mortality. According to the studies from Budhiraja et al.⁷⁶ (2015) and Greenberg and Goss⁷⁷ (2009), optimal management of these diseases requires treatment for both conditions in order to improve overall outcomes, including pharmacological and non-pharmacological, such as the cessation of tobacco use, oxygen supplementation, education about sleep hygiene, among others.

Discussion

Our results show that all medical guidelines address some aspects of lifestyle, but the only document that highlights all six pillars was the document from 2019 on cardiovascular prevention. Despite this, a literature search showed that there is evidence that all the pillars can help in NCD control; however, they were not mentioned by the guidelines. The most common pillars found were physical activity, nutrition, and toxic control.

The impact of lifestyle changes on NCDs are difficult to assess in randomized clinical trials for several reasons, including ethical aspects. Factors, such as sleep deprivation or encouraging the use of drugs or alcohol consumption, are unethical, for example. For these reasons, most of the evidence available in the literature and displayed in our results is based on epidemiological studies²⁵-³⁶,⁴¹,⁴⁴,⁴⁵,⁴⁸,⁵²,⁵⁴,⁵⁶-⁶¹,⁶⁵-⁶⁹,⁷³-⁷⁵.

A direct comparison between clinical guidelines and lifestyle recommendations has only been previously performed by Lewthwaite et al.⁶² (2017) in a systematic review study associating physical activity and sleep behaviors in COPD guidelines. Thus, this increases the importance of our study by including all pillars of lifestyle whilst addressing more than one NCD.

Medical guidelines are documents that contain the best scientific evidence available on a topic, used to improve the quality of care for patients and improve clinical effectiveness.⁷⁸ However, most of the guidelines nowadays focus on the treatment process, mainly pharmacological ones, discarding important approaches related to lifestyle and preventive mechanisms.

Nonetheless, it is noted that the guidelines have increasingly incorporated lifestyle aspects into their recommendations. In the Guidelines from the Brazilian Diabetes Society from 2019-2020, the only pillars mentioned were physical activity and diet.⁷⁹ However, in 2022, psychosocial aspects, which are extremely relevant for the patient, were incorporated.²⁴ Those same lifestyle pillars were added in the most recent guideline published on hypertension, both as both preventive and treatment tools.⁸⁰ More recently, in the end of 2022, after the closure of the present study, a position statement was published on Women's Cardiovascular Health with recommendations of aspects related to all lifestyle pillars as a preventive measure for cardiovascular diseases.⁸¹ It is expected to be a trend, and thus a good attitude for other guidelines to trigger the incorporation of other pillars, as was done in the 2019 Cardiovascular Prevention Guideline, which fits cardiovascular diseases in a generic way.

Limitations

Among the limitations, the studies gathered for analysis, which serve as a basis for demonstrating the effects of the lifestyle pillars on disease management, are not necessarily randomized clinical trials, due mainly to the ethical reasons already discussed above. The search for articles related to lifestyle and the subjects of the studied guidelines did not meet the rigors of a systematic review, since it was not within the scope of this article.

Furthermore, this study focused on Brazilian medical guidelines, not extending the analysis and comparison to American or European guidelines. Although NCDs are a global problem, the national sphere was chosen first to raise awareness.

Future steps

When studying lifestyle and its impact on health processes, little is said about environmental and socioeconomic aspects. The Cardiovascular Prevention Guideline published in 2019, addressed in this study, presents a section on the impact of these factors on health care, which is a new line of study to be explored that may even fit as a future lifestyle pillar not related to behavioral measures.

In addition, another possible way to improve this study is to report on the NCDs that cause the most deaths in Brazil, not only considering the ICD-10 category informed by the SIM.

Conclusion

Rarely are the six pillars of lifestyle contemplated in Brazilian guidelines for AMI, DM, and COPD. The literature review identified evidence of all lifestyle pillars to offer a holistic approach for the management and prevention of these NCDs.

* Supplemental Materials

For additional information, please click here.

References

• ¹ Ernita M, Wibowo A. Tackling Non-communicable Diseases in Asia Countries Systematic Review. KnE Life Sci. 2019;4(10):358-64. doi: 10.18502/kls.v4i10.3739.
  » https://doi.org/10.18502/kls.v4i10.3739
• ² World Health Organization. Noncommunicable diseases [Internet]. Geneva: WHO; 2023 [cited 2023 Nov 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
  » https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
• ³ Schmidt MI, Duncan BB, Silva GA, Menezes AM, Monteiro CA, Barreto SM, et al. Chronic Non-Communicable Diseases in Brazil: Burden and Current Challenges. Lancet. 2011;377(9781):1949-61. doi: 10.1016/S0140-6736(11)60135-9.
  » https://doi.org/10.1016/S0140-6736(11)60135-9
• ⁴ Hwu YJ. The Impact of Chronic Illness on Patients. Rehabil Nurs. 1995;20(4):221-5. doi: 10.1002/j.2048-7940.1995.tb01632.x.
  » https://doi.org/10.1002/j.2048-7940.1995.tb01632.x
• ⁵ Baanders AN, Heijmans MJ. The Impact of Chronic Diseases: the Partner‘s Perspective. Fam Community Health. 2007;30(4):305-17. doi: 10.1097/01.FCH.0000290543.48576.cf.
  » https://doi.org/10.1097/01.FCH.0000290543.48576.cf
• ⁶ Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of Chronic Disease in the 21st Century: Elimination of the Leading Preventable Causes of Premature Death and Disability in the USA. Lancet. 2014;384(9937):45-52. doi: 10.1016/S0140-6736(14)60648-6.
  » https://doi.org/10.1016/S0140-6736(14)60648-6
• ⁷ American College of Lifestyle Medicine. Reversing chronic disease with evidence-based lifestyle medicine [Internet]. Chesterfield: American College of Lifestyle Medicine; 2021 [cited 2021 Nov 4]. Disponível em: https://lifestylemedicine.org/ACLM/About/What_is_Lifestyle_Medicine/ACLM/About/What_is_Lifestyle_Medicine_/Lifestyle_Medicine.aspx?hkey=26f3eb6b-8294-4a63-83de-35d429c3bb88
  » https://lifestylemedicine.org/ACLM/About/What_is_Lifestyle_Medicine/ACLM/About/What_is_Lifestyle_Medicine_/Lifestyle_Medicine.aspx?hkey=26f3eb6b-8294-4a63-83de-35d429c3bb88
• ⁸ Phillips EM, Frates EP, Park DJ. Lifestyle Medicine. Phys Med Rehabil Clin N Am. 2020;31(4):515-26. doi: 10.1016/j.pmr.2020.07.006.
  » https://doi.org/10.1016/j.pmr.2020.07.006
• ⁹ Ockene JK, Sorensen G, Kabat-Zinn J, Ockene IS, Donnelly G. Benefits and Costs of Lifestyle Change to Reduce Risk of Chronic Disease. Prev Med. 1988;17(2):224-34. doi: 10.1016/0091-7435(88)90065-5.
  » https://doi.org/10.1016/0091-7435(88)90065-5
• ¹⁰ Burton DA, Stokes K, Hall GM. Physiological effects of exercise. Contin Educ Anaesthesia, Crit Care Pain. 2004;4:185-8. doi: 10.1093/bjaceaccp/mkh050.
  » https://doi.org/10.1093/bjaceaccp/mkh050
• ¹¹ European Lung Foundation. Your Lungs and Exercise [Internet]. Sheffield: European Lung Foundation; 2016 [cited 2023 Nov 21]; Available from: https://europeanlung.org/en/information-hub/factsheets/your-lungs-and-exercise/#:~:text=When%20you%20exercise%20and%20your,litres%20of%20air)%20during%20exercise
  » https://europeanlung.org/en/information-hub/factsheets/your-lungs-and-exercise/#:~:text=When%20you%20exercise%20and%20your,litres%20of%20air)%20during%20exercise
• ¹² Radak Z, Zhao Z, Koltai E, Ohno H, Atalay M. Oxygen Consumption and Usage During Physical Exercise: the Balance Between Oxidative Stress and ROS-Dependent Adaptive Signaling. Antioxid Redox Signal. 2013;18(10):1208-46. doi: 10.1089/ars.2011.4498.
  » https://doi.org/10.1089/ars.2011.4498
• ¹³ Rahati S, Shahraki M, Arjomand G, Shahraki T. Food Pattern, Lifestyle and Diabetes Mellitus. Int J High Risk Behav Addict. 2014;3(1):e8725. doi: 10.5812/ijhrba.8725.
  » https://doi.org/10.5812/ijhrba.8725
• ¹⁴ Zielinski MR, McKenna JT, McCarley RW. Functions and Mechanisms of Sleep. AIMS Neurosci. 2016;3(1):67-104. doi: 10.3934/Neuroscience.2016.1.67.
  » https://doi.org/10.3934/Neuroscience.2016.1.67
• ¹⁵ Yoon U, Kwok LL, Magkidis A. Efficacy of Lifestyle Interventions in Reducing Diabetes Incidence in Patients with Impaired Glucose Tolerance: a Systematic Review of Randomized Controlled Trials. Metabolism. 2013;62(2):303-14. doi: 10.1016/j.metabol.2012.07.009.
  » https://doi.org/10.1016/j.metabol.2012.07.009
• ¹⁶ Zini EM, Lanzola G, Bossi P, Quaglini S. An Environment for Guideline-Based Decision Support Systems for Outpatients Monitoring. Methods Inf Med. 2017;56(4):283-93. doi: 10.3414/ME16-01-0142.
  » https://doi.org/10.3414/ME16-01-0142
• ¹⁷ Brasil. Ministério da Saúde. Conheça a Conitec [Internet]. Brasília, DF: Ministério da Saúde; 2022 [cited 2023 Nov 21]. Available from: https://www.gov.br/conitec/pt-br/assuntos/a-comissao/conheca-a-conitec
  » https://www.gov.br/conitec/pt-br/assuntos/a-comissao/conheca-a-conitec
• ¹⁸ Brasil. Ministério da Saúde. Sistema de Informações sobre Mortalidade (SIM) [Internet]. Brasília, DF: Ministério da Saúde; 2023 [cited 2023 Nov 21]. Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sim/cnv/obt10uf.def
  » http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sim/cnv/obt10uf.def
• ¹⁹ Cesar LA, Ferreira JF, Armaganijan D, Gowdak LH, Mansur AP, Bodanese LC, et al. Diretriz de Doença Coronária Estável. Arq Bras Cardiol. 2014;103(2 Suppl 2):360-413. doi: 10.5935/abc.2014S004.
  » https://doi.org/10.5935/abc.2014S004
• ²⁰ Avezum Á Jr, Feldman A, Carvalho AC, Sousa AC, Mansur AP, Bozza AE, et al. V Guideline of the Brazilian Society of Cardiology on Acute Myocardial Infarction Treatment with ST Segment Elevation. Arq Bras Cardiol. 2015;105(2 Suppl 1):1-105. doi: 10.5935/abc.20150107.
  » https://doi.org/10.5935/abc.20150107
• ²¹ Précoma DB, Oliveira GMM, Simão AF, Dutra OP, Coelho OR, Izar MCO, et al. Atualização da Diretriz de Prevenção Cardiovascular da Sociedade Brasileira de Cardiologia - 2019. Arq. Bras. Cardiol. 2019;113(4):787-891. doi: 10.5935/abc.20190204.
  » https://doi.org/10.5935/abc.20190204
• ²² Nicolau JC, Feitosa Filho GS, Petriz JL, Furtado RHM, Précoma DB, Lemke W, et al. Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST - 2021. Arq. Bras. Cardiol. 2021;117(1):181-264. doi: 10.36660/abc.20210180.
  » https://doi.org/10.36660/abc.20210180
• ²³ Brasil. Ministério da Saúde. Relatório de recomendação: Protocolo Clínico e Diretrizes Terapêuticas da Doença Pulmonar Obstrutiva Crônica. Brasília, DF: Ministério da Saúde; 2021.
• ²⁴ Sociedade Brasileira de Diabetes. Diretriz da Sociedade Brasileira de Diabetes. Sociedade Brasileira de Diabetes [Internet]. 2022 [cited 2023 Nov 21]. Available from: https://diretriz.diabetes.org.br/
  » https://diretriz.diabetes.org.br/
• ²⁵ Andrechuk CR, Ceolim MF. Sleep Quality and Adverse Outcomes for Patients with Acute Myocardial Infarction. J Clin Nurs. 2016;25(1-2):223-30. doi: 10.1111/jocn.13051.
  » https://doi.org/10.1111/jocn.13051
• ²⁶ Eaker ED, Pinsky J, Castelli WP. Myocardial Infarction and Coronary Death Among Women: Psychosocial Predictors from a 20-Year Follow-Up of Women in the Framingham Study. Am J Epidemiol. 1992;135(8):854-64. doi: 10.1093/oxfordjournals.aje.a116381.
  » https://doi.org/10.1093/oxfordjournals.aje.a116381
• ²⁷ Qureshi AI, Giles WH, Croft JB, Bliwise DL. Habitual Sleep Patterns and Risk for Stroke and Coronary Heart Disease: a 10-Year Follow-Up from NHANES I. Neurology. 1997;48(4):904-11. doi: 10.1212/wnl.48.4.904.
  » https://doi.org/10.1212/wnl.48.4.904
• ²⁸ Newman AB, Spiekerman CF, Enright P, Lefkowitz D, Manolio T, Reynolds CF, et al. Daytime Sleepiness Predicts Mortality and Cardiovascular Disease in Older Adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc. 2000;48(2):115-23. doi: 10.1111/j.1532-5415.2000.tb03901.x.
  » https://doi.org/10.1111/j.1532-5415.2000.tb03901.x
• ²⁹ Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. A Prospective Study of Sleep Duration and Coronary Heart Disease in Women. Arch Intern Med. 2003;163(2):205-9. doi: 10.1001/archinte.163.2.205.
  » https://doi.org/10.1001/archinte.163.2.205
• ³⁰ Liu Y, Tanaka H. Overtime Work, Insufficient Sleep, and Risk of Non-Fatal Acute Myocardial Infarction in Japanese Men. Occup Environ Med. 2002;59(7):447-51. doi: 10.1136/oem.59.7.447.
  » https://doi.org/10.1136/oem.59.7.447
• ³¹ Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. N Engl J Med. 2005;353(19):2034-41. doi: 10.1056/NEJMoa043104.
  » https://doi.org/10.1056/NEJMoa043104
• ³² Bradley TD, Logan AG, Kimoff RJ, Sériès F, Morrison D, Ferguson K, et al. Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure. N Engl J Med. 2005;353(19):2025-33. doi: 10.1056/NEJMoa051001.
  » https://doi.org/10.1056/NEJMoa051001
• ³³ Lao XQ, Liu X, Deng HB, Chan TC, Ho KF, Wang F, et al. Sleep Quality, Sleep Duration, and the Risk of Coronary Heart Disease: a Prospective Cohort Study with 60,586 Adults. J Clin Sleep Med. 2018;14(1):109-17. doi: 10.5664/jcsm.6894.
  » https://doi.org/10.5664/jcsm.6894
• ³⁴ Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, Verschuren WM. Sufficient Sleep Duration Contributes to Lower Cardiovascular Disease Risk in Addition to Four Traditional Lifestyle Factors: the MORGEN Study. Eur J Prev Cardiol. 2014;21(11):1367-75. doi: 10.1177/2047487313493057.
  » https://doi.org/10.1177/2047487313493057
• ³⁵ Nielsen TJ, Vestergaard M, Christensen B, Christensen KS, Larsen KK. Mental Health Status and Risk of New Cardiovascular Events or Death in Patients with Myocardial Infarction: a Population-Based Cohort Study. BMJ Open. 2013;3(8):e003045. doi: 10.1136/bmjopen-2013-003045.
  » https://doi.org/10.1136/bmjopen-2013-003045
• ³⁶ Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTERHEART Study): Case-Control Study. Lancet. 2004;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9.
  » https://doi.org/10.1016/S0140-6736(04)17018-9
• ³⁷ Mohamed MO, Rashid M, Farooq S, Siddiqui N, Parwani P, Shiers D, et al. Acute Myocardial Infarction in Severe Mental Illness: Prevalence, Clinical Outcomes, and Process of Care in U.S. Hospitalizations. Can J Cardiol. 2019;35(7):821-830. doi: 10.1016/j.cjca.2019.04.021.
  » https://doi.org/10.1016/j.cjca.2019.04.021
• ³⁸ Valtorta NK, Kanaan M, Gilbody S, Ronzi S, Hanratty B. Loneliness and Social Isolation as Risk Factors for Coronary Heart Disease and Stroke: Systematic Review and Meta-Analysis of Longitudinal Observational Studies. Heart. 2016;102(13):1009-16. doi: 10.1136/heartjnl-2015-308790.
  » https://doi.org/10.1136/heartjnl-2015-308790
• ³⁹ Holt-Lunstad J, Smith TB. Loneliness and Social Isolation as Risk Factors for CVD: Implications for Evidence-Based Patient Care and Scientific Inquiry. Heart. 2016;102(13):987-9. doi: 10.1136/heartjnl-2015-309242.
  » https://doi.org/10.1136/heartjnl-2015-309242
• ⁴⁰ Mookadam F, Arthur HM. Social Support and its Relationship to Morbidity and Mortality After Acute Myocardial Infarction: Systematic Overview. Arch Intern Med. 2004;164(14):1514-8. doi: 10.1001/archinte.164.14.1514.
  » https://doi.org/10.1001/archinte.164.14.1514
• ⁴¹ Biddinger KJ, Emdin CA, Haas ME, Wang M, Hindy G, Ellinor PT, et al. Association of Habitual Alcohol Intake with Risk of Cardiovascular Disease. JAMA Netw Open. 2022;5(3):e223849. doi: 10.1001/jamanetworkopen.2022.3849.
  » https://doi.org/10.1001/jamanetworkopen.2022.3849
• ⁴² Mostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA. Alcohol and Immediate Risk of Cardiovascular Events: a Systematic Review and Dose-Response Meta-Analysis. Circulation. 2016;133(10):979-87. doi: 10.1161/CIRCULATIONAHA.115.019743.
  » https://doi.org/10.1161/CIRCULATIONAHA.115.019743
• ⁴³ Lee SWH, Ng KY, Chin WK. The Impact of Sleep Amount and Sleep Quality on Glycemic Control in Type 2 Diabetes: a Systematic Review and Meta-Analysis. Sleep Med Rev. 2017;31:91-101. doi: 10.1016/j.smrv.2016.02.001.
  » https://doi.org/10.1016/j.smrv.2016.02.001
• ⁴⁴ Lou P, Chen P, Zhang L, Zhang P, Yu J, Zhang N, et al. Relation of Sleep Quality and Sleep Duration to Type 2 Diabetes: a Population-Based Cross-Sectional Survey. BMJ Open. 2012;2(4):e000956. doi: 10.1136/bmjopen-2012-000956.
  » https://doi.org/10.1136/bmjopen-2012-000956
• ⁴⁵ Luyster FS, Dunbar-Jacob J. Sleep Quality and Quality of Life in Adults with Type 2 Diabetes. Diabetes Educ. 2011;37(3):347-55. doi: 10.1177/0145721711400663.
  » https://doi.org/10.1177/0145721711400663
• ⁴⁶ van Cauter E, Holmback U, Knutson K, Leproult R, Miller A, Nedeltcheva A, et al. Impact of Sleep and Sleep Loss on Neuroendocrine and Metabolic Function. Horm Res. 2007;67(Suppl 1):2-9. doi: 10.1159/000097543.
  » https://doi.org/10.1159/000097543
• ⁴⁷ Mosavat M, Mirsanjari M, Arabiat D, Smyth A, Whitehead L. The Role of Sleep Curtailment on Leptin Levels in Obesity and Diabetes Mellitus. Obes Facts. 2021;14(2):214-21. doi: 10.1159/000514095.
  » https://doi.org/10.1159/000514095
• ⁴⁸ Nilsson PM, Rööst M, Engström G, Hedblad B, Berglund G. Incidence of Diabetes in Middle-Aged Men is Related to Sleep Disturbances. Diabetes Care. 2004;27(10):2464-9. doi: 10.2337/diacare.27.10.2464.
  » https://doi.org/10.2337/diacare.27.10.2464
• ⁴⁹ U.S. Department of Health and Human Services. Smoking and Diabetes Fact Sheet. Atlanta: Centers for Disease Control and Prevention; 2014.
• ⁵⁰ U.S. Food and Drug Administration FDA. Cigarette Smoking: a Risk Factor for Type 2 Diabetes. U.S. Food and Drug Administration FDA [Internet]. 2020 [cited 2023 Nov 22]. Available from: https://www.fda.gov/tobacco-products/health-effects-tobacco-use/cigarette-smoking-risk-factor-type-2-diabetes
  » https://www.fda.gov/tobacco-products/health-effects-tobacco-use/cigarette-smoking-risk-factor-type-2-diabetes
• ⁵¹ Arnson Y, Shoenfeld Y, Amital H. Effects of Tobacco Smoke on Immunity, Inflammation and Autoimmunity. J Autoimmun. 2010;34(3):J258-65. doi: 10.1016/j.jaut.2009.12.003.
  » https://doi.org/10.1016/j.jaut.2009.12.003
• ⁵² Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers. Smoking as a Cause of Oxidative Damage. N Engl J Med. 1995;332(18):1198-203. doi: 10.1056/NEJM199505043321804.
  » https://doi.org/10.1056/NEJM199505043321804
• ⁵³ Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, et al. Alcohol as a Risk Factor for Type 2 Diabetes: a Systematic Review and Meta-Analysis. Diabetes Care. 2009;32(11):2123-32. doi: 10.2337/dc09-0227.
  » https://doi.org/10.2337/dc09-0227
• ⁵⁴ Wannamethee SG, Shaper AG, Perry IJ, Alberti KG. Alcohol Consumption and the Incidence of Type II Diabetes. J Epidemiol Community Health. 2002;56(7):542-8. doi: 10.1136/jech.56.7.542.
  » https://doi.org/10.1136/jech.56.7.542
• ⁵⁵ Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional Associations Between Clinically Relevant Depression or Anxiety and COPD: a Systematic Review and Meta-Analysis. Chest. 2013;144(3):766-77. doi: 10.1378/chest.12-1911.
  » https://doi.org/10.1378/chest.12-1911
• ⁵⁶ Montserrat-Capdevila J, Godoy P, Marsal JR, Ortega M, Pifarré J, Alsedà M, et al. Mental Disorders in Chronic Obstructive Pulmonary Diseases. Perspect Psychiatr Care. 2018;54(3):398-404. doi: 10.1111/ppc.12274.
  » https://doi.org/10.1111/ppc.12274
• ⁵⁷ Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, et al. Depression, Anxiety and Health Status After Hospitalisation for COPD: a Multicentre Study in the Nordic Countries. Respir Med. 2006;100(1):87-93. doi: 10.1016/j.rmed.2005.04.003.
  » https://doi.org/10.1016/j.rmed.2005.04.003
• ⁵⁸ Sorli-Aguilar M, Martin-Lujan F, Flores-Mateo G, Arija-Val V, Basora-Gallisa J, Sola-Alberich R, et al. Dietary Patterns are Associated with Lung Function Among Spanish Smokers without Respiratory Disease. BMC Pulm Med. 2016;16(1):162. doi: 10.1186/s12890-016-0326-x.
  » https://doi.org/10.1186/s12890-016-0326-x
• ⁵⁹ Hirayama F, Lee AH, Binns CW. Dietary Factors for Chronic Obstructive Pulmonary Disease: Epidemiological Evidence. Expert Rev Respir Med. 2008;2(5):645-53. doi: 10.1586/17476348.2.5.645.
  » https://doi.org/10.1586/17476348.2.5.645
• ⁶⁰ Rodríguez-Rodríguez E, Ortega RM, Andrés P, Aparicio A, González-Rodríguez LG, López-Sobaler AM, et al. Antioxidant Status in a Group of Institutionalised Elderly People with Chronic Obstructive Pulmonary Disease. Br J Nutr. 2016;115(10):1740-7. doi: 10.1017/S0007114516000878.
  » https://doi.org/10.1017/S0007114516000878
• ⁶¹ McKeever TM, Lewis SA, Smit HA, Burney P, Cassano PA, Britton J. A Multivariate Analysis of Serum Nutrient Levels and Lung Function. Respir Res. 2008;9(1):67. doi: 10.1186/1465-9921-9-67.
  » https://doi.org/10.1186/1465-9921-9-67
• ⁶² Lewthwaite H, Effing TW, Olds T, Williams MT. Physical Activity, Sedentary Behaviour and Sleep in COPD Guidelines: a Systematic Review. Chron Respir Dis. 2017;14(3):231-44. doi: 10.1177/1479972316687224.
  » https://doi.org/10.1177/1479972316687224
• ⁶³ Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, Batlle J, Ramon MA, Rodriguez E, et al. Benefits of Physical Activity on COPD Hospitalisation Depend on Intensity. Eur Respir J. 2015;46(5):1281-9. doi: 10.1183/13993003.01699-2014.
  » https://doi.org/10.1183/13993003.01699-2014
• ⁶⁴ Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular Physical Activity Reduces Hospital Admission and Mortality in Chronic Obstructive Pulmonary Disease: a Population Based Cohort Study. Thorax. 2006;61(9):772-8. doi: 10.1136/thx.2006.060145.
  » https://doi.org/10.1136/thx.2006.060145
• ⁶⁵ Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary Effects of Chronic Obstructive Pulmonary Disease on Physical Activity: a Cross-Sectional Study. Am J Respir Crit Care Med. 2008;177(7):743-51. doi: 10.1164/rccm.200707-1011OC.
  » https://doi.org/10.1164/rccm.200707-1011OC
• ⁶⁶ Waschki B, Kirsten A, Holz O, Müller KC, Meyer T, Watz H, et al. Physical Activity is the Strongest Predictor of All-Cause Mortality in Patients with COPD: a Prospective Cohort Study. Chest. 2011;140(2):331-42. doi: 10.1378/chest.10-2521.
  » https://doi.org/10.1378/chest.10-2521
• ⁶⁷ Dogra S, Good J, Buman MP, Gardiner PA, Copeland JL, Stickland MK. Physical Activity and Sedentary Time are Related to Clinically Relevant Health Outcomes Among Adults with Obstructive Lung Disease. BMC Pulm Med. 2018;18(1):98. doi: 10.1186/s12890-018-0659-8.
  » https://doi.org/10.1186/s12890-018-0659-8
• ⁶⁸ Dinicola G, Julian L, Gregorich SE, Blanc PD, Katz PP. The Role of Social Support in Anxiety for Persons with COPD. J Psychosom Res. 2013;74(2):110-5. doi: 10.1016/j.jpsychores.2012.09.022.
  » https://doi.org/10.1016/j.jpsychores.2012.09.022
• ⁶⁹ Marino P, Sirey JA, Raue PJ, Alexopoulos GS. Impact of Social Support and Self-Efficacy on Functioning in Depressed Older Adults with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2008;3(4):713-8. doi: 10.2147/copd.s2840.
  » https://doi.org/10.2147/copd.s2840
• ⁷⁰ Barton C, Effing TW, Cafarella P. Social Support and Social Networks in COPD: a Scoping Review. COPD. 2015;12(6):690-702. doi: 10.3109/15412555.2015.1008691.
  » https://doi.org/10.3109/15412555.2015.1008691
• ⁷¹ Kutty K. Sleep and Chronic Obstructive Pulmonary Disease. Curr Opin Pulm Med. 2004;10(2):104-12. doi: 10.1097/00063198-200403000-00004.
  » https://doi.org/10.1097/00063198-200403000-00004
• ⁷² Fleetham J, West P, Mezon B, Conway W, Roth T, Kryger M. Sleep, Arousals, and Oxygen Desaturation in Chronic Obstructive Pulmonary Disease. The Effect of Oxygen Therapy. Am Rev Respir Dis. 1982;126(3):429-33. doi: 10.1164/arrd.1982.126.3.429.
  » https://doi.org/10.1164/arrd.1982.126.3.429
• ⁷³ Vukoja M, Kopitovic I, Milicic D, Maksimovic O, Pavlovic-Popovic Z, Ilic M. Sleep Quality and Daytime Sleepiness in Patients with COPD and Asthma. Clin Respir J. 2018;12(2):398-403. doi: 10.1111/crj.12528.
  » https://doi.org/10.1111/crj.12528
• ⁷⁴ Serin EK, Ister ED, Ozdemir A. The Relationship Between Sleep Quality and Dyspnoea Severity in Patients with COPD. Afr Health Sci. 2020;20(4):1785-92. doi: 10.4314/ahs.v20i4.32.
  » https://doi.org/10.4314/ahs.v20i4.32
• ⁷⁵ Omachi TA, Blanc PD, Claman DM, Chen H, Yelin EH, Julian L, et al. Disturbed Sleep Among COPD Patients is Longitudinally Associated with Mortality and Adverse COPD Outcomes. Sleep Med. 201213(5):476-83. doi: 10.1016/j.sleep.2011.12.007.
  » https://doi.org/10.1016/j.sleep.2011.12.007
• ⁷⁶ Budhiraja R, Siddiqi TA, Quan SF. Sleep Disorders in Chronic Obstructive Pulmonary Disease: Etiology, Impact, and Management. J Clin Sleep Med. 2015;11(3):259-70. doi: 10.5664/jcsm.4540.
  » https://doi.org/10.5664/jcsm.4540
• ⁷⁷ Greenberg J, Goss JB. Therapies for Insomnia and Comorbid Chronic Obstructive Pulmonary Disease with a Focus on Ramelteon (Rozerem). P T. 2009;34(9):502-8.
• ⁷⁸ Natsch S, van der Meer JW. The Role of Clinical Guidelines, Policies and Stewardship. J Hosp Infect. 2003;53(3):172-6. doi: 10.1053/jhin.2002.1372.
  » https://doi.org/10.1053/jhin.2002.1372
• ⁷⁹ Sociedade Brasileira de Diabetes. Diretrizes Sociedade Brasileira de Diabetes [Internet]. São Paulo: Sociedade Brasileira de Diabetes; 2020 [cited 2023 Nov 22]. Available from: https://www.saude.ba.gov.br/wp-content/uploads/2020/02/Diretrizes-Sociedade-Brasileira-de-Diabetes-2019-2020.pdf
  » https://www.saude.ba.gov.br/wp-content/uploads/2020/02/Diretrizes-Sociedade-Brasileira-de-Diabetes-2019-2020.pdf
• ⁸⁰ Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, et al. Brazilian Guidelines of Hypertension - 2020. Arq Bras Cardiol. 2021;116(3):516-658. doi: 10.36660/abc.20201238.
  » https://doi.org/10.36660/abc.20201238
• ⁸¹ Oliveira GMM, Almeida MCC, Santos CM, Costa MENC, Carvalho RCM, Freire CMV, et al. Position Statement on Women's Cardiovascular Health - 2022. Arq Bras Cardiol. 2022;119(5):815-82. doi: 10.36660/abc.20220734.
  » https://doi.org/10.36660/abc.20220734

• Sources of funding
  There were no external funding sources for this study.
• Study association
  This study is not associated with any thesis or dissertation work.
• Ethics approval and consent to participate
  This article does not contain any studies with human participants or animals performed by any of the authors.

Edited by

• Editor responsible for the review: Gláucia Maria Moraes de Oliveira

Publication Dates

• Publication in this collection
  08 Jan 2024
• Date of issue
  2023

History

• Received
  20 June 2023
• Reviewed
  29 Aug 2023
• Accepted
  25 Oct 2023